Atea Pharmaceuticals, Inc. vs. GILEAD SCIENCES, INC.,

Explore the PTAB proceeding PGR2023-00046 filed by Atea Pharmaceuticals, Inc. on 2023-08-07. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

PGR2023-00046

Filing Date

2023-08-07

Accorded Filing Date

2023-08-07

Institution Decision Date

2024-02-21

Last Modified Date

2024-06-07

Proceeding Type

PGR

Termination Date

2024-02-21

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Atea Pharmaceuticals, Inc.

Represented By

Knowles, Sherryet al

Patent Owner / Respondent

GILEAD SCIENCES, INC.,

Represented By

Shear, Williamet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 17077267

Respondent Patent Number 11642361

External Links

Espacenet

Google Patents

Respondent Inventor Jinfa Du et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

36 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Gilead Sciences, Inc. - c/o Sheppard Mullin Richter & Hampton LLP

Customer Number 117796

Address 650 Town Center Drive, 10th Floor, Costa Mesa, CA, 92626, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
36727	Daniel Yannuzzi	858-720-8924
40314	David Rubin	917-319-9571
46226	Jennifer Wahlsten	650-372-4447
46567	Brandon Boss	650-522-4626
50782	Lorna Tanner	650-815-2658
53551	Tony Sanny	650-522-4225
55140	Mary Edwards	650-522-1816
56856	Manali Dighe	707-731-3817
60523	Alex Nie	650-815-2600
62991	Achim Brinker	619-398-6322
63686	Alexis Simpson	404-885-3098
63700	Timothy Marquart	650-358-8046
63866	Lacie Hirayama	650-815-2628
63954	Katharine Rice	650-577-7829
67163	Joy Lynn Nemirow	650-815-2600
67296	Michael Smith	530-624-5906
67405	Tara Stuart	678-490-6776
69481	Lucia Muntean	650-522-5813
69729	Patricia Rose	650-439-7525
69996	Reena Bajpai	650-849-3049
70890	Xin Xie	703-597-4249
71507	Miguel Lopez	310-229-9904
72362	Jiangqiong Liu	650-574-3000
73686	Dana Broughton-Johnson	843-209-2885
73733	Lydia Choi	650-653-9461
75110	Russell Romeo	650-235-2431
75560	Nathan Lee	714-424-8273
76571	Shelley Lai	650-372-7600
76828	Eric Lee	650-425-2744
77602	Paola Dozzo	415-713-8805
77620	Wenlan Chen	614-266-3458
78832	Ryann Muir	650-524-3920
79719	Darrin Flanigan	650-528-0835
80093	Young Chang	415-774-2932
80191	Joshua Seitz	650-522-2437
80227	Yi Shi	650-352-1954

Proceeding Documents

156

Notice: refund approved NOTICE

2024-06-07 FILING PARTY: BOARD

Download

Request for Redund OTHER

2024-05-31 FILING PARTY: PETITIONER

Download

DECISION Denying Institution of Post-Grant Review 35 U.S.C. § 324(a) DECISION

2024-02-21 FILING PARTY: BOARD

Download

2024

Part 1 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1-288) Exhibit

2023-11-22 FILING PARTY: PATENT OWN

Download

2023

Part 3 - File history for U.S. Patent App. No. 16/817,318 (pp. 457-684) Exhibit

2023-11-22 FILING PARTY: PATENT OWN

Download

Atea Pharmaceuticals, Inc. vs. GILEAD SCIENCES, INC.,

Proceeding Overview

Parties & Counsel

Petitioner

Atea Pharmaceuticals, Inc. Follow

Represented By

Patent Owner / Respondent

GILEAD SCIENCES, INC., Follow

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Notice: refund approved NOTICE

Request for Redund OTHER

DECISION Denying Institution of Post-Grant Review 35 U.S.C. § 324(a) DECISION

Part 1 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1-288) Exhibit

Part 3 - File history for U.S. Patent App. No. 16/817,318 (pp. 457-684) Exhibit

Peiyuan Wang LinkedIn Profile Exhibit

Part 3 - File history for U.S. Patent App. No. 16/516,192 (pp. 588-776) Exhibit

Part 3 - Partial file history for U.S. Patent No. 8,735,372 (pp. 591-830) Exhibit

Part 1 - Partial file history for U.S. Patent No. 8,334,270 (pp. 1-434) Exhibit

Part 2 - File history for U.S. Patent App. No. 16/817,318 (pp. 227-456) Exhibit

U.S. Patent No. 8,957,046 Exhibit

Part 2 - Partial file history for U.S. Patent No. 8,735,372 (pp. 289-590) Exhibit

Part 9 - Partial file history for U.S. Patent No. 8,957,046 (pp. 1997-2019) Exhibit

Part 2 - Partial file history for U.S. Patent No. 8,906,880 (pp. 243-467) Exhibit

Part 3 - U.S. Patent No. 7,608,600 (pp. 723-1104) Exhibit

Part 5 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1083-1382) Exhibit

Part 1 - Partial file history for U.S. Patent No. 8,957,046 (pp. 1-215) Exhibit

Dhanapalan Nagarathnam LinkedIn Profile Exhibit

Part 5 - Partial file history for U.S. Patent No. 8,580,765 (pp. 1707-2156) Exhibit

Atea Pharmaceuticals Founder, Chairman & CEO: Jean-Pierre Sommadossi Exhibit

Part 3 - File history for U.S. Patent No. 11,642,361 (pp. 452-676) Exhibit

Part 1 - Partial file history for U.S. Patent No. 10,183,037 (pp. 1-225) Exhibit

“Gilead Remains Steadfast in Support for Hepatitis C Elimination Efforts”, Gilead Press Release (April 3, 2023) Exhibit

Part 2 - File history for U.S. Patent App. No. 16/516,192 (pp. 285-587) Exhibit

Part 2 - Partial file history for U.S. Patent No. 8,580,765 (pp. 433-848) Exhibit

Part 2 - File history for U.S. Patent App. No. 16/169,878 (pp. 185-418) Exhibit

Part 4 - File history for U.S. Patent App. No. 16/169,878 (pp. 655-811) Exhibit

Part 4 - U.S. Patent No. 7,608,600 (pp. 1105-1129) Exhibit

Part 10 - File history for U.S. Patent No. 11,642,361 (pp. 2251-2552) Exhibit

Part 1 - File history for U.S. Patent No. 11,642,361 (pp. 1-222) Exhibit

Part 8 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1971-2245) Exhibit

Part 3 - Partial file history for U.S. Patent No. 9,085,573 (pp. 863-1312) Exhibit

U.S. Patent No. 7,429,572 Exhibit

Clark et al., “Design, Synthesis, and Antiviral Activity of 2′-Deoxy-2′-fluoro-2′-C-methylcytidine, a Potent Inhibitor of Hepatitis C Virus Replication”, J. Med. Chem. 2005, 48, 5504-5508 Exhibit

Part 2 - U.S. Patent No. 7,608,600 (pp. 349-722) Exhibit

Part 7 - Partial file history for U.S. Patent No. 8,580,765 (pp. 2562-2915) Exhibit

Part 4 - Partial file history for U.S. Patent No. 8,580,765 (pp. 1289-1706) Exhibit

Part 7 - Partial file history for U.S. Patent No. 8,735,372 (pp. 1684-1970) Exhibit

Part 7 - Partial file history for U.S. Patent No. 8,957,046 (pp. 1457-1737) Exhibit

Part 1 - Partial file history for U.S. Patent No. 9,085,573 (pp. 1-435) Exhibit

Part 4 - File history for U.S. Patent No. 11,642,361 (pp. 677-900) Exhibit

Part 2 - Partial file history for U.S. Patent No. 7,964,580 (pp. 409-818) Exhibit

Part 2 - Partial file history for U.S. Patent No. 8,334,270 (pp. 435-862) Exhibit

Part 4 - Partial file history for U.S. Patent No. 9,085,573 (pp. 1313-1712) Exhibit

“Hepatitis C replicon system and drug development”, 2016 Lasker-DeBakey Clinical Medical Research Award Exhibit

Part 4 - Partial file history for U.S. Patent No. 8,735,372 (pp. 831-1082) Exhibit

Part 2 - Partial file history for U.S. Patent No. 10,183,037 (pp. 226-460) Exhibit

Part 4 - Partial file history for U.S. Patent No. 8,957,046 (pp. 671-877) Exhibit

Part 3 - Partial file history for U.S. Patent No. 8,334,270 (pp. 863-1152) Exhibit

Part 6 - Partial file history for U.S. Patent No. 9,085,573 (pp. 2153-2574) Exhibit

Patent Owner's Exhibit List NOTICE

Part 9 - File history for U.S. Patent No. 11,642,361 (pp. 1965-2250) Exhibit

U.S. Patent No. 7,608,597 Exhibit

U.S. Patent No. 8,906,880 Exhibit

Part 2 - Partial file history for U.S. Patent No. 8,957,046 (pp. 216-438) Exhibit

Part 3 - Partial file history for U.S. Patent No. 8,906,880 (pp. 468-700) Exhibit

Part 3 - Partial file history for U.S. Patent No. 10,183,037 (pp. 461-697) Exhibit

Part 2 - File history for U.S. Patent No. 11,642,361 (pp. 223-451) Exhibit

Gilead Sciences v. Nucana PLC [2023] EWHC 611 (Pat); Case No: HP-2021-000007 (Approved Judgment) Exhibit

Part 1 - File history for U.S. Patent App. No. 16/169,878 (pp. 1-184) Exhibit

File history excerpts of Utility Patent Application Transmittal Sheets for Idenix Pharmaceuticals, Inc.’s U.S. Patent Nos. 6,914,054; 7,608,597; and 7,608,600 Exhibit

“FDA Approves Gilead's Hepatitis C Drug”, Wall Street Journal (December 6, 2013) Exhibit

Part 6 - Partial file history for U.S. Patent No. 8,957,046 (pp. 1171-1456) Exhibit

Part 11 - File history for U.S. Patent No. 11,642,361 (pp. 2553-2741) Exhibit

U.S. Patent No. 8,735,372 Exhibit

Atea Pharmaceuticals, Inc.

GILEAD SCIENCES, INC.,